Bioorganic and Medicinal Chemistry Letters p. 3676 - 3681 (2011)
Update date:2022-08-02
Topics:
Chowdhury, Sultan
Chafeev, Mikhail
Liu, Shifeng
Sun, Jianyu
Raina, Vandna
Chui, Ray
Young, Wendy
Kwan, Rainbow
Fu, Jianmin
Cadieux, Jay A.
Starting from the oxindole 2a identified through a high-throughput screening campaign, a series of NaV1.7 blockers were developed. Following the elimination of undesirable structural features, preliminary optimization of the oxindole C-3 and N-1 substituents afforded the simplified analogue 9b, which demonstrated a 10-fold increase in target potency versus the original HTS hit. A scaffold rigidification strategy then led to the discovery of XEN907, a novel spirooxindole NaV1.7 blocker. This lead compound, which in turn showed a further 10-fold increase in potency, represents a promising structure for further optimization efforts.
View MoreHebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
HaiNan Periwinkle Pharmaceutical Co.,Ltd.
website:http://www.cchpharm.com/en/index.html
Contact:020-82208978
Address:Gongye road,Wuzhishan city,HaiNan province
Hangzhou jls Flame Retardants Chemical Co.,Ltd
Contact:+86-571-87250387/87250386
Address:MOGANSHAN RODA 1418# SHANGCHENG INDUSTRIAL PARK
website:http://www.chinabarton.com
Contact:+86-573-82719618
Address:No. 162 Fumin Road, Honghe Town,
Contact:86-25-51817806
Address:No. 216, middle longpan road, jincheng tower, floor 21-22, nanjing ,china
Doi:10.1039/c8nj04579h
(2018)Doi:10.1021/ja062978n
(2006)Doi:10.1007/BF00758995
(1984)Doi:10.1021/jo0484070
(2005)Doi:10.1021/acs.joc.9b00277
(2019)Doi:10.1021/np060219c
(2006)